Lusardi Completes Laboratory Renovation for the FDA in Lenexa, Kansas

“The FDA Lenexa Laboratory is a relocation of the current Kansas City District Laboratory and features a number of upgraded capabilities for the FDA to conduct its mission. The 40% increase over the existing location is a new state of the art laboratory that will service Total Diet and Pesticides Research Center (TDPRC), Pesticides analysis, Chemotherapeutics / LC-MS Poison screening, Mycotoxins analysis, Drugs and Dietary Supplements analysis, Dioxins analysis, Metals / Elemental Specialization analysis, and Laboratory Administration.” -Easterly Government Properties

 

The project encompassed a renovation and expansion of an existing 35,000 SF building to approximately 60,000 SF. The improvements include a new mechanical room structure, a rooftop equipment penthouse, rooftop equipment screening, additional parking and site improvements, and research and industrial labs inside the building. This is a full-service laboratory with functions that include testing of foods, feeds, dietary supplements, pesticides, and industrial chemicals. The interior space also includes laboratory support areas, hazardous materials storage space, approximately 5,000 SF of clean room area, and office areas.  The user requirements for this facility include emergency backup power, by way of emergency generators, fully redundant HVAC systems, high-purity medical gas systems, and a loading dock space for receiving deliveries. Special systems include closed circuit television, access control throughout the building, and a high-end building management and automation system.

 

Lusardi deployed in-house carpenter and laborer crews to Lenexa, KS to help assist the project team and subcontractors with related tasks on the jobsite.  By self-performing some of the work, this allowed the project team the most efficient control of scheduling, quality and cost. Lusardi journeymen carpenters, concrete finishers and laborers pride themselves in producing some of the finest finished projects in the industry. 

 

During the course of construction, weather played a huge factor during the winter and spring months with record amounts of snow, ice and rain. This prevented the project from getting out of the ground and delayed roofing and site finish work during the wet spring. Material delays also played a role in the project schedule as the COVID 19 pandemic forced supplier shops to close or put items on back order. 

 

“It’s a beautiful thing when a plan comes together. Turnover of the design-build FDA Lab wouldn’t have been possible without our design partners Henderson Engineers & HKS Architects. Great work on this amazing facility.” -Gabe Halsey, Senior Project Manager.

Warner and Debbie Lusardi Donate $25 Million to Scripps Memorial Encinitas

SCRIPPS HEALTH – News from Scripps Health

 

Largest gift in Scripps Encinitas history will fund new hospital tower and pulmonary institute

 

ENCINITAS, Calif. – Philanthropists Warner and Debbie Lusardi of Rancho Santa Fe have given Scripps Memorial Hospital Encinitas the largest donation in its history, a $25 million investment to help fund a new acute care hospital tower and pulmonary institute that are cornerstones of the hospital’s master plan.

 

 “We are immensely grateful to Warner and Debbie Lusardi, whose historic gift will have a truly transformative impact on the region’s health care for generations to come,” said Chris Van Gorder, president and chief executive officer of Scripps Health. “This investment will provide North County residents with expanded access to the high-quality, compassionate health care they have come to expect from Scripps Encinitas.”

 

 Lusardi Tower

 

The new hospital building, to be called Lusardi Tower, will be a three-story, 224,000-square-foot facility that will offer abroad range of patient care services. It will include 64 inpatient beds that will be used for a variety of clinical needs, including medical-surgical care, intensive care and progressive (or intermediate) care, as well as additional operating suites.

 

Scripps expects site work to begin at the hospital in early 2022, with the first phase of Lusardi Tower expected to be open for patient care in 2025. The tower will be situated between the existing main hospital building and the Leichtag Foundation Critical Care Pavilion.

 

All patient rooms in Lusardi Tower will be private and will offer abundant natural light. Each room will be designed with ample space, giving patients a more comfortable environment and caregivers more space to efficiently deliver care. Lusardi Tower will include the latest in wireless health technology and advanced digital monitoring and telemedicine capabilities.

 

Lusardi Pulmonary Institute

 

Lusardi Tower also will be home to the new Lusardi Pulmonary Institute, which will provide the full spectrum of patient care for respiratory conditions. The institute will expand on the hospital’s existing state-of-the-art interventional pulmonary medicine program, including the early detection of lung cancer, minimally invasive diagnostic lung biopsy, thoracic surgery and treatment of asthma, chronic obstructive pulmonary disease and sleep-related disorders. It will provide the complete continuum of inpatient and outpatient care, including prevention, diagnosis, treatment, rehabilitation and research.

 

“An investment of this magnitude will allow us to take a significant step forward for our patients, their families and the entire caregiving team, making Scripps Encinitas a top destination for health care,” said Scott Eisman, M.D., physician chief operating executive at Scripps Encinitas. “We’ve seen demand for health care services increase steadily over the past decade at Scripps Encinitas, and with continuing population growth expected, it’s critical that we take steps now to prepare for the future.”

 

Master plan highlights

 

Lusardi Tower and Lusardi Pulmonary Institute are key components of the second and final phase of a master plan that is well under way at Scripps Encinitas. Another phase-two project, a three-story, 68,000-square-foot medical office pavilion located on the northernmost portion of the hospital campus, is currently under construction, with completion expected next year.

 

Phase one of the hospital’s master plan was completed in 2016. It includes the Leichtag Foundation Critical Care Pavilion, which offers an emergency department and a medical-surgical unit.

 

Lusardi’s legacy of giving

 

Warner and Debbie Lusardi have a long history of supporting Scripps Encinitas and the entire Scripps Health system. They helped launch Scripps Encinitas’ current fundraising campaign with a $1.1 million gift. An additional $65,000 in donations by the Lusardi’s enabled the hospital to upgrade its operating rooms and acquire two separate pieces of diagnostic technology to detect respiratory issues and bladder cancer.

 

“The Lusardi family has deep roots in San Diego County, and this generous gift is a testament to their legacy of leadership and altruism, which will continue to have a significant impact on our community for generations to come,” said John Engle, corporate senior vice president and chief development officer with Scripps Health. “We couldn’t be more proud for this vital addition to Scripps Encinitas to bear the Lusardi name.”

 

Beyond Scripps Encinitas, Warner and Debbie Lusardi donated generously to support the Prebys Cardiovascular Institute and the Scripps Whittier Diabetes Institute.